Immunofluorescence tests. Clinical significance of sera and skin in bullous diseases.
D000906:Antibodies / Q000032:analysis*; D000914:Antibodies, Viral / Q000032:analysis; D001706:Biopsy; D003874:Dermatitis Herpetiformis / Q000175:diagnosis; D004820:Epidermolysis Bullosa / Q000175:diagnosis; D004892:Erythema Multiforme / Q000175:diagnosis; D005260:Female; D005455:Fluorescent Antibody Technique; D005891:Gingivitis / Q000175:diagnosis; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D008010:Lichen Planus / Q000175:diagnosis; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis; D006559:Pemphigoid Gestationis / Q000175:diagnosis; D010391:Pemphigoid, Bullous / Q000175:diagnosis; D010392:Pemphigus / Q000175:diagnosis; D011164:Porphyrias / Q000175:diagnosis; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis; D012867:Skin / Q000473:pathology; D012872:Skin Diseases, Vesiculobullous / Q000175:diagnosis* / Q000473:pathology
D000906:Antibodies; D000914:Antibodies, Viral; D007070:Immunoglobulin A; D007074:Immunoglobulin G